| 000 | 01812 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250512104129.0 | ||
| 264 | 0 | _c19700617 | |
| 008 | 197006s 0 0 fre d | ||
| 022 | _a0004-4172 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChaillet, F | |
| 245 | 0 | 0 |
_a[Studies on substances in the benzofuran group. 43. Angiotrophic, anti-inflammatory and fibrinolytic properties of benzarone]. _h[electronic resource] |
| 260 |
_bArzneimittel-Forschung _cMar 1970 |
||
| 300 |
_a358-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetylcholine _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 |
_aBenzofurans _xpharmacology |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 |
_aBradykinin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
| 650 | 0 | 4 |
_aCapillary Resistance _xdrug effects |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDepression, Chemical |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aEdema _xprevention & control |
| 650 | 0 | 4 |
_aEpinephrine _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolysis _xdrug effects |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xpharmacology |
| 650 | 0 | 4 | _aGuinea Pigs |
| 650 | 0 | 4 |
_aHistamine H1 Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aMycobacterium Infections _xprevention & control |
| 650 | 0 | 4 |
_aNorepinephrine _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aSerotonin Antagonists |
| 650 | 0 | 4 | _aStimulation, Chemical |
| 650 | 0 | 4 |
_aVascular Diseases _xdrug therapy |
| 700 | 1 | _aBarchewitz, G | |
| 700 | 1 | _aCharlier, R | |
| 700 | 1 | _aGuilbert, A | |
| 700 | 1 | _aColot, M | |
| 700 | 1 | _aDeltour, G | |
| 773 | 0 |
_tArzneimittel-Forschung _gvol. 20 _gno. 3 _gp. 358-63 |
|
| 999 |
_c4397296 _d4397296 |
||